NCT04155814View on ClinicalTrials.gov

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
Bioequivalance
Interventions
DRUG

Iron Sucrose Injection

USP 100 mg/5 mL (20 mg/mL), solution for IV injection, 100 mg unit dose strength

DRUG

Venofer Injection

(Iron Sucrose 20 mg/mL), solution for IV injection, 100 mg unit dose strength

Trial Locations (1)

33126

Baxter Investigational Site, Miami

All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

lead

Baxter Healthcare Corporation

INDUSTRY

NCT04155814 - Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter